A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 20,908 shares of EBS stock, worth $161,200. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,908
Holding current value
$161,200
% of portfolio
0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$7.72 - $11.97 $161,409 - $250,268
20,908 New
20,908 $199,000
Q3 2023

Nov 14, 2023

BUY
$3.17 - $7.91 $34,226 - $85,404
10,797 New
10,797 $36,000
Q2 2022

Aug 15, 2022

SELL
$27.42 - $43.63 $375,242 - $597,076
-13,685 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$36.48 - $52.22 $499,228 - $714,630
13,685 New
13,685 $562,000
Q4 2021

Feb 14, 2022

SELL
$33.11 - $55.01 $170,516 - $283,301
-5,150 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$50.07 - $66.05 $411,475 - $542,798
-8,218 Reduced 61.48%
5,150 $258,000
Q2 2021

Aug 16, 2021

SELL
$56.61 - $80.46 $224,854 - $319,587
-3,972 Reduced 22.91%
13,368 $842,000
Q1 2021

May 17, 2021

SELL
$86.23 - $125.19 $8,709 - $12,644
-101 Reduced 0.58%
17,340 $1.61 Million
Q4 2020

Feb 16, 2021

SELL
$79.17 - $111.47 $1.44 Million - $2.03 Million
-18,185 Reduced 51.04%
17,441 $1.56 Million
Q3 2020

Nov 16, 2020

BUY
$81.91 - $134.94 $1.96 Million - $3.22 Million
23,886 Added 203.46%
35,626 $3.68 Million
Q2 2020

Aug 13, 2020

SELL
$54.33 - $89.52 $101,434 - $167,133
-1,867 Reduced 13.72%
11,740 $928,000
Q1 2020

May 15, 2020

BUY
$49.34 - $68.76 $143,234 - $199,610
2,903 Added 27.12%
13,607 $787,000
Q3 2019

Nov 14, 2019

BUY
$40.6 - $57.2 $95,288 - $134,248
2,347 Added 28.08%
10,704 $560,000
Q2 2019

Aug 14, 2019

BUY
$39.92 - $53.86 $333,611 - $450,108
8,357 New
8,357 $404,000
Q1 2019

May 15, 2019

SELL
$48.23 - $66.16 $1.99 Million - $2.74 Million
-41,352 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$55.63 - $73.24 $1.64 Million - $2.15 Million
29,414 Added 246.39%
41,352 $2.45 Million
Q3 2018

Nov 14, 2018

SELL
$52.05 - $66.51 $450,388 - $575,511
-8,653 Reduced 42.02%
11,938 $786,000
Q2 2018

Aug 14, 2018

SELL
$48.33 - $55.64 $30,206 - $34,775
-625 Reduced 2.95%
20,591 $1.04 Million
Q1 2018

May 15, 2018

SELL
$44.44 - $54.39 $662,600 - $810,954
-14,910 Reduced 41.27%
21,216 $1.12 Million
Q4 2017

Feb 14, 2018

SELL
$37.77 - $47.75 $4.43 Million - $5.59 Million
-117,168 Reduced 76.43%
36,126 $1.68 Million
Q3 2017

Nov 14, 2017

BUY
$34.14 - $40.45 $5.23 Million - $6.2 Million
153,294
153,294 $6.2 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $384M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.